1800 103 7100
info@mohanfoundation.org
MOHAN Foundation

Menu

Skip to content
  • About
  • Free Downloads
  • Videos

Life...

Let's Pass it on...

Know More

Organs wasted are lives lost....

Become an Organ Donor-Saves Lives...

Know More

Don't Take your organs to Heaven...

Know More

Organ Donation

If you save one life,It is as though you save the world

11Dec/11

Stem Cell Transplant: Physical, Mental Health Burdens Persist – Internal Medicine News Digital Network

December 11, 2011Other Transplantationadmin

Fox NewsStem Cell Transplant: Physical, Mental Health Burdens PersistInternal Medicine News Digital NetworkSAN DIEGO – Long after the event, hematopoietic stem cell recipients still bear a heavier burden of physical and emotional problems than do the…

11Dec/11

ASH: Rituximab Dosing Schemes Prove Equal in Low-Burden FL – MedPage Today

December 11, 2011Monoclonal Anti-CD20 Antibodiesadmin

ASH: Rituximab Dosing Schemes Prove Equal in Low-Burden FLMedPage TodayExplain that maintenance therapy with rituximab (Rituxan) in low-burden follicular lymphoma provided disease control that was as good as rituximab retreatment at progression. Point …

11Dec/11

Rituximab and Liposomal Doxorubicin Improve Progression-Free and Overall … – Monthly Prescribing Reference

December 11, 2011Monoclonal Anti-CD20 Antibodiesadmin

Rituximab and Liposomal Doxorubicin Improve Progression-Free and Overall …Monthly Prescribing ReferenceSAN DIEGO, CA—At the 53rd American Society of Hematology Annual Meeting and Exposition, study investigators presented evidence demonstrating prom…

11Dec/11

Blood donation day at local female college – Saudi Gazette

December 11, 2011Organ Donoradmin

Blood donation day at local female collegeSaudi GazetteBy Doha Ghouth JEDDAH – To help others and raise awareness about donating blood, the female branch of the College of Business Administration (CBA) is hosting a Blood Donation Day today, in cooper…

11Dec/11

PBSCs from unrelated donors associated with higher rates of chronic GVHD – HemOncToday

December 11, 2011Organ Donoradmin

PBSCs from unrelated donors associated with higher rates of chronic GVHDHemOncTodayWhile PBSCs from related donors have been shown to have clinical benefit, Anasetti told HemOnc Today that these results show that PSBCs from unrelated donors put patient…

11Dec/11

R-BAC Effective In Patients With Mantle Cell Lymphoma Not Eligible for … – Monthly Prescribing Reference

December 11, 2011Monoclonal Anti-CD20 Antibodiesadmin

R-BAC Effective In Patients With Mantle Cell Lymphoma Not Eligible for …Monthly Prescribing ReferenceSAN DIEGO, CA—The rituximab, bendamustine, and cytarabine (R-BAC) chemotherapy regimen was shown to be effective in previously untreated patients &…

11Dec/11

Rituximab Plus Pulse Dexamethasone Effective, Tolerable in Patients with … – Monthly Prescribing Reference

December 11, 2011Monoclonal Anti-CD20 Antibodiesadmin

Rituximab Plus Pulse Dexamethasone Effective, Tolerable in Patients with …Monthly Prescribing ReferenceSAN DIEGO, CA—Standard-dose rituximab plus multiple courses of pulse dexamethasone was shown to be active with manageable toxicity in patients wi…

11Dec/11

Study Favors As-Needed Treatment Over Maintenance Therapy for Patients with … – NEWS.GNOM.ES (press release)

December 11, 2011Monoclonal Anti-CD20 Antibodiesadmin

Study Favors As-Needed Treatment Over Maintenance Therapy for Patients with …NEWS.GNOM.ES (press release)ES/ – Asymptomatic patients diagnosed with nonbulky follicular lymphoma, a slow-growing type of non-Hodgkin lymphoma, have traditionally been w…

11Dec/11

ASH 2011 Multiple Myeloma Update – Day One – The Myeloma Beacon

December 11, 2011Other Transplantationadmin

ASH 2011 Multiple Myeloma Update – Day OneThe Myeloma BeaconThe second is maintenance therapy, which is longer-term therapy that patients often receive after induction therapy and (usually) a stem cell transplant. Dr. Reece explained that a large num…

11Dec/11

Emerging Lymphoma and Myeloma Treatments Focus on Improving Individual Patient … – PR Newswire (press release)

December 11, 2011Monoclonal Anti-CD20 Antibodiesadmin

Emerging Lymphoma and Myeloma Treatments Focus on Improving Individual Patient …PR Newswire (press release)The first clinical trial to directly compare rituximab with the new anti-CD20 monoclonal antibody obinutuzumab for the treatment of relapsed no…

Posts navigation

  • « Previous
  • 1
  • …
  • 18,294
  • 18,295
  • 18,296
  • 18,297
  • 18,298
  • …
  • 18,561
  • Next »

Categories

  • Antibodies
  • Blood donation
  • Bone marrow donation and transplantation
  • Brain Death Declaration
  • Chronic Allograft Nephropathy
  • Donor Card
  • Drugs/Medicine
  • Google News RSS feed URL deprecation
  • Heart
  • HLA Typing
  • Immunosuppressive Drugs
  • Infectious Disease
  • Intestinal
  • Islet
  • Kidney
  • Liver
  • Lung
  • Monoclonal Anti-CD20 Antibodies
  • Monoclonal Anti-IL-2Rα Receptor Antibodies
  • Nephrology
  • Organ Donation
  • Organ Donor
  • Organ Failure
  • Organ Preservation Methods
  • Organ Preservation Solution
  • Organs
  • Other Transplantation
  • Pancreas
  • Pharma News
  • Polyclonal Anti-T-Cell Antibodies
  • Tissue Donation
  • Transplant laws
  • Transplant Rejection
  • Transplant Studies
  • Transplant Surgery
  • Transplant Tourism
  • Transplant Trials
  • Transplantation
  • Uncategorized
Copyright © MOHAN Foundation
Powered by WordPress , Theme i-excel by TemplatesNext.
MENU
    • About
    • Free Downloads
    • Videos